Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy of Mifepristone (RU-486) in the Treatment of Bipolar Depression.

Trial Profile

Efficacy of Mifepristone (RU-486) in the Treatment of Bipolar Depression.

Phase of Trial: Phase II

Latest Information Update: 14 Oct 2017

At a glance

  • Drugs Mifepristone (Primary)
  • Indications Bipolar disorders
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 01 Dec 2012 Primary endpoint 'Cambridge-Neuropsychological-Test-Automated-Battery' has not been met.
    • 24 Sep 2008 Planned end date changed from Sep 2009 to Dec 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top